Kolexia
Seguin Lorene
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
41 Activités
335 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du sein triple-négatives COVID-19 Carboplatine {{person.topmesh6.name}} {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

Ipsen
3 collaboration(s)
Dernière en 2023
Daiichi Sankyo
2 collaboration(s)
Dernière en 2023
AstraZeneca
2 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2023

Dernières activités

COG STIM 2: Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer: a Multicenter Randomized Controlled Trial
Essai Clinique (Centre François-Baclesse)   11 septembre 2023
The French General Population's Perception of New Information and Communication Technologies for Medical Consultations: National Survey.
Journal of medical Internet research   16 juin 2023
Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of and Loss of .
JCO precision oncology   01 février 2022
E-health, digitalization, or digital transformation: Impact on cancer supportive care.
Bulletin du cancer   19 janvier 2022
L’association entre l’hormonothérapie, la chimiothérapie et la qualité de vie cinq ans après un diagnostic de cancer du sein : résultats de l’enquête VICAN5
SI: 69/S1 - EPICLIN 2021   01 juin 2021
Advance Approval of Outpatient Chemotherapy via Phone Call Optimizes Healthcare Delivery without Compromising Patient Satisfaction with Care.
Cancers   16 mars 2021
Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey.
Cancers   20 novembre 2020
1881P Deterioration of sexual health of cancer survivors 5 years after diagnosis – French national cohort VICAN
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine
Abstract Book of Molecular Analysis for Personalised Therapy (MAP) 2018 14–15 September, Paris, France   01 septembre 2018
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}